Pfizer Inc (PFE) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite.

Total Assets Chart for Pfizer Inc

Pfizer Inc (PFE) total assets for FY2025 were USD 208.2B, a -2.5% change from FY2024. Pfizer Inc's total assets grew from USD 4.5B in 1985 to USD 208.2B in 2025 (4564.2% over 40 years). Total assets compound annual growth rate: 5-year CAGR of 6.2%, 10-year CAGR of 2.2%, 20-year CAGR of 2.9%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$149.33B
Implied Share Price
$26.20
Enterprise Value
$196.32B
Revenue (TTM)
$63.70B
EBITDA
$25.38B
Profit Margin
6.80%
Trailing P/E
34.03
Forward P/E
8.67
Price/Book (MRQ)
1.70
Price/Sales (TTM)
2.34
EV/EBITDA
14.55
EV/Revenue
3.08
Dividend Yield
6.66%
Book Value
$14.95
Free Cash Flow (FY2025)
$9.08B
Free Cash Flow Yield
6.08%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.